Track 1:Antibiotics

• Track 1-1Introduction to antibiotic uses and challenges

• Track 1-2Basic principles of prescribing antibiotics

• Track 1-3Mechanisms of bacteriostatic or bactericidal action

Track 2:The Emergence of Antimicrobial Resistance

• Track 2-1Antimicrobial Stewardship

• Track 2-2Bacterial antibiotic resistance

• Track 2-3Alternate strategy to overcome the problem of antimicrobial resistance worldwide

• Track 2-4Mechanism of antimicrobial resistance

• Track 2-5Genetics of antimicrobial resistance

• Track 2-6Proteomics of antimicrobial resistance

• Track 2-7Antimicrobial resistance

• Track 2-8 A public approach to antimicrobial resistance

• Track 2-9Novel sntibacterial drug discovery

• Track 2-10 Preventing drug resistance

Track 3:Antibiotic Resistance: Opportunities and Challenges

• Track 3-1Antibiotics and alternatives

• Track 3-2Systemic intervention – values, conflict and blue room resolution

• Track 3-3Grand challenges – antimicrobial resistance

• Track 3-4Intervention against antimicrobial resistance – approaches and implementation

Track 4:Drug Discovery and Novel Delivery Technologies

• Track 4-1Policies to stimulate drug development and discovery

• Track 4-2Role of computational biology

• Track 4-3Ligand binding studies

• Track 4-4Transport (simulation studies)

• Track 4-5Molecule mediating transport

Track 5:Antibiotics for Emerging and Re-emerging Diseases

• Track 5-1Resistance and re-emerging theories

• Track 5-2Medication procedures

• Track 5-3Medication procedures

• Track 5-4Molecular mechanism of resistance

• Track 5-5New drugs for emerging diseases

Track 6:Antibiotics and Mechanism of Action

• Track 6-1Broad spectrum

• Track 6-2Narrow spectrum

• Track 6-3Nuclear material

• Track 6-4Protein

• Track 6-5Pharmacokinetics of Antibiotics

• Track 6-6Pharmacodynamics of Antibiotics

Track 7:Different Types of Antibiotics and their Applications

• Track 7-1Hypocholesterolemic agents

• Track 7-2Lipopeptide

• Track 7-3Macrolides

• Track 7-4Monobactams

• Track 7-5Nitrofurans

• Track 7-6Oxazolidinones

• Track 7-7Polypeptides

• Track 7-8Quinolones

• Track 7-9Sulfonamides

• Track 7-10Tetracyclines

• Track 7-11Lincosamides

• Track 7-12Glycopeptides

• Track 7-13Immunosuppressive agents

• Track 7-14Anti-migraine agents

• Track 7-15Anti-bacterials

• Track 7-16Antifungals

• Track 7-17Penicillins

• Track 7-18Aminoglycosides

• Track 7-19Ansamycins

• Track 7-20Carbapenems

• Track 7-21Cephalosporins (1,2, 3, 4, 5 generations)

• Track 7-22Fluoroquinolones

Track 8:Micro Organisms in Recent Drug Discovery

• Track 8-1Novel species discovery

• Track 8-2Micos from different areas (patients, geographical locations)

• Track 8-3Geneticlly modified organisms

Track 9:Clinical Trials of Antibiotics

• Track 9-1Evaluations of efficacy

• Track 9-2Evaluations of safety

• Track 9-3Clinical biochemistry & clinical microbiology

Track 10:Modern Antibiotics for Various Diseases and Infections

• Track 10-1Novel antibacterial drug discovery

• Track 10-2Skin and soft tissue infections

• Track 10-3Urinary tract infections

• Track 10-4Acute diarrhea, gastroenteritis, and food poisoning (Campylobacteriosis)

• Track 10-5Sepsis

• Track 10-6Infective endocarditis

• Track 10-7Osteomyelitis

• Track 10-8Common gynecologic Infections

• Track 10-9Fever and apparent acute central nervous system Infection

• Track 10-10Upper respiratory tract infections

• Track 10-11Treatment for common infections

• Track 10-12Water born diseases

• Track 10-13Modern Antibiotics: Emerging trends, Barriers and Opportunities

• Track 10-14Pulmonary Infections

• Track 10-15Malaria

• Track 10-16Arthritis

• Track 10-17Antibiotics for Child Care

• Track 10-18Dental related problems

• Track 10-19Inflammatory and infectious diseases

• Track 10-20Allergies

• Track 10-21Antibiotics in anti-aging

Track 11:Antibiotic Regulatory Affairs

• Track 11-1National and International laws

• Track 11-2Frame work of new laws (International understanding)

• Track 11-3 Different systems of operating laws (communication between market and officer desk)

Track 12:Advances in Antibiotic Treatment

• Track 12-1Randomized Control Trails

• Track 12-2Empiric Antibiotic Therapy

• Track 12-3Bacterial Biofilms

• Track 12-4Intra-Adhesive Antibiotics

• Track 12-5Oral Antibiotic Therapy

• Track 12-6Immunomodulation

Track 13:Antibiotics for Cancer

• Track 13-1Can antibiotics be used to fight cancer?

• Track 13-2Antibiotics used in acne treatments to treat common cancers

• Track 13-3Antibiotics against lung cancer cells

• Track 13-4Antibiotics for Colon Cancer

• Track 13-5Antibiotics and breast cancer treatment

• Track 13-6FDA-approved antibiotics for anti-cancer therapy

• Track 13-7Antimicrobial adjuvant therapy in cancer treatment

• Track 13-8Role of antibiotics in killing cancer stem cells

• Track 13-9Anticancer Antibiotics

• Track 13-10Antibiotics Can Increase Your Risk of Cancer!

Track 14:Antibiotics: In Pregnancy and Lactation

• Track 14-1Safe use of anti‐infective agents

• Track 14-2Current investigations in broad spectrum antibiotics

• Track 14-3Antibiotics and neurological damage

Track 15:Antibiotics for Diabetes

• Track 15-1Antibiotic Use Linked to Type 1 Diabetes Diagnosis

• Track 15-2Does giving children antibiotics increases their risk of diabetes?

• Track 15-3Antibiotics for Treatment of Diabetic Foot Infections

• Track 15-4Antibiotics versus good bacteria in gut

• Track 15-5Fluoroquinolone antibiotics and type 2 diabetes mellitus

• Track 15-6Antibiotics and Risk for Diabetes

Track 16:Antibiotics: Market Analysis & Business Opportunities

• Track 16-1Global antibiotics market

• Track 16-2Antibiotics market Europe

• Track 16-3Antibiotics market USA

• Track 16-4Antibiotics market UK

Track 17:Entrepreneurs Investment Meet
Track 18:Antibiotic Prophylaxis

• Track 18-1Prevention of microbial infection

• Track 18-2Antibiotic selection

• Track 18-3Advantages of long-acting antibiotics

Track 19:Antibiotics in Different Industries

• Track 19-1Antibiotics in food Industry

• Track 19-2Antibiotics in agriculture

• Track 19-3Antibiotics in veterinary

• Track 19-4Antibiotics in aquaculture